Table S3: On-Line Supplementary (Table S3): Factors Associated with HAART Regimen Change at 12 Months after Initiation.

TOTAL
COHORT
N(%) or
Median(IQR)
N=610
CAUCASIAN
N(%) or
Median(IQR)
N=271
AFRICAN-AMERICAN
N(%) or
Median (IQR)
N=231
HISPANIC
N(%) or
Median(IQR)
N=63
OTHER
N(%) or
Median(IQR)
N=45
P-VALUE
Age(years) 34 (10.0) 35 (10.0) 33 (12.0) 32 (12.0) 33 (11.0) <0.0001
Viral load at HAART
Initiation (log copies/ml)
0.8210
<400 34 (5.6%) 19 (7.01%) 12 (5.2%) 2 (3.2%) 1 (2.2%)
400-<1000 47 (7.7%) 24 (8.9%) 16 (6.9%) 4 (6.4%) 3 (6.7%)
1000-<10000 131 (21.5%) 63 (23.3%) 44 (19.1%) 13 (20.3%) 11 (24.4%)
>=10000 381 (62.5%) 156 (57.6%) 154 (66.7%) 43 (68.3%) 28 (62.2%)
Missing 17 (2.8%) 9 (3.3%) 5 (2.2%) 1 (1.6%) 2 (4.4%)
CD4 Cell Count at
HAART initiation (cells/ml)
0.3764
<200 203 (33.3%) 89 (32.8%) 78 (33.8%) 24 (38.1%) 12 (26.7%)
200-<350 165 (27.1%) 70 (25.8%) 71 (30.7%) 13 (20.6%) 11 (24.4%)
>=350 216 (35.4%) 100 (36.9%) 71 (30.7%) 26 (41.3%) 19 (42.2%)
Missing 26 (4.3%) 12 (4.4%) 11 (4.8%) 0 (0%) 3 (6.7%)
ARV Prior to HAART (%) 365 (59.8%) 172 (63.5%) 139 (60.2%) 35 (55.6%) 19 (42.2%) 0.0506
Major Depression 196 (32.1%) 87 (32.1%) 73 (31.6%) 20 (31.8%) 16 (35.6%) 0.9645
Hemoglobin(g/dL) 14 (2.1) 14.4 (2.4) 13.6 (1.9) 14.7 (1.7) 14.8 (1.8) <0.0001

Abbreviations: HAART, highly active antiretroviral therapy; ARV, antiretroviral.